US2006100289A1PendingUtilityA1
Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
Est. expiryOct 15, 2022(expired)· nominal 20-yr term from priority
A61P 29/00C07C 309/73C07C 309/46A61P 19/02C07C 2601/14C07D 309/12A61P 17/02C07C 311/51C07C 311/21C07C 291/02
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are nitrone compounds and pharmaceutical compositions containing such compounds. The nitrone compounds have one to six additional carbons bridging between the nitrone functionality and the nitrone aryl ring. The disclosed compositions are useful as therapeutics for inflammation-related conditions and analgesia in mammals, such as arthritis, and for neuropathic pain and traumatic injuries such as traumatic brain injury and acute spinal cord injury.
Claims
exact text as granted — not AI-modified1 - 18 . (canceled)
19 . A pharmaceutical composition comprising a pharmaceutically inert, injectable, sustained release carrier and a pharmaceutically effective amount of N-tert-butyl-4-acetamidobenzamide.
20 . The pharmaceutical composition of claim 19 wherein said N-tert-butyl-4-acetamidobenzamide comprises 0.1 to 50 weight percent of said pharmaceutical composition.
21 . The pharmaceutical composition of claim 20 wherein said N-tert-butyl-4-acetamidobenzamide comprises 1 to 40 weight percent of said pharmaceutical composition.
22 . The pharmaceutical composition of claim 19 wherein said N-tert-butyl-4-acetamidobenzamide comprises 0.05 to 10 weight percent of said pharmaceutical composition.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.